University of California San Francisco
Give to UCSFSeth Blumberg, MD, PhD, an assistant professor of medicine, is clinical specialist in infectious disease, including Monkeypox. He offers insight in the recent outbreak in a Q&A.
A significant proportion of bacterial sexually transmitted infections – gonorrhea, chlamydia, or syphilis – were prevented with a dose of doxycycline after unprotected sex, according to preliminary results of a clinical trial.
Natalia Jura, an associate professor in the Department of Cellular and Molecular Pharmacology and an investigator at the UCSF Cardiovascular Research Institute, is the 27th recipient of the annual Byers Award.
Nevan Krogan, PhD, director of UCSF’s Quantitative Biosciences Institute, examines in detail the effects of a handful of genes that seem to play an outsize role in a wide array of diseases.
Scientists at UCSF QBI and the QBI Coronavirus Research Group (QCRG) have been awarded $67.5 million from the National Institute of Allergy and Infectious Diseases (NIAID) to support its mission of pandemic preparedness.
Keith Yamamoto, PhD, a leader in precision medicine and the vice chancellor of Science Policy and Strategy at UCSF, has been elected president of the American Association for the Advancement of Science, the largest scientific society in the world.
UCSF and Johns Hopkins University announced the addition of 1.4 million documents to their Opioid Industry Documents Archive from Mallinckrodt, a leading generic opioid manufacturer now in bankruptcy.
An antiviral drug approved for high-risk COVID patients may also benefit those with long COVID, according to the findings of a small case series that need to be confirmed with future rigorous studies.
Kathy Giacomini, PhD, who trained as a pharmacist and went on to become one of the foremost experts on pharmacogenomics with a focus on drug transporters, has been appointed dean of the UCSF School of Pharmacy.
For 29 years, Rashetta Higgins was wracked by epileptic seizures. UCSF neurologists used a pioneering imaging technique to spot what was triggering them and then removed that region from her brain. Now Rashetta is living a seizure-free life.
Wei Gordon was among nine finalists in the sixth annual UCSF Grad Slam, held March 31 – after a two-year hiatus due to the pandemic – competing to inform and entertain with three-minute talks based on their own research.
In a study, UCSF neurologist William Seeley, MD, and colleagues identified two key moments in the natural history of Alzheimer’s, pointing to a window of opportunity for treatment with amyloid-lowering drugs.
Brain tumor patients survived longer when treated aggressively with surgery, radiation and chemotherapy. Now, a UCSF study underscores the critical role of genomic profiling in diagnosing and grading brain tumors.
In a recent study, UCSF researchers looked at the efficacy of hybrid and virtual delivery of cardiac rehabilitation (CR). They found that virtual and hybrid CR services produced similar improvements in patient function as in-person CR.
Skin diseases both common and rare can be better diagnosed and treated using genetic fingerprinting based on knowledge gained through a new UCSF study, according to researchers who developed new approaches for using the latest techniques to analyze gene activity in cells obtained from affected skin.
UCSF, in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA), has developed the OneSource system to seamlessly integrate clinical care and research data.
Stephen L. Hauser, MD, Professor of Neurology and Director of the UCSF Weill Institute for Neurosciences, has been chosen by the American Brain Foundation (ABF) to receive its second annual Scientific Breakthrough Award.
For the new study published in the journal Nature on March 30, 2022, researchers at Gladstone Institutes, the Salk Institute for Biological Studies, and UC San Francisco (UCSF) teamed up. Their findings, shed light on how obesity can change the immune system and, potentially, how clinicians might be able to better treat allergies and asthma in obese people.
UCSF’s Division of Hematology-Oncology is welcoming Krishna Komanduri, MD, as division chief of Hematology-Oncology at UCSF Health. Komanduri is an international leader in the fields of hematology-oncology, transplantation, and cellular immunotherapy. He will start at UCSF on July 1.